DJIA 17,959.44 154.64 0.87%
NASDAQ 4,781.42 16.04 0.34%
S&P 500 2,078.54 7.89 0.38%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? - Analyst Blog

The 5 Most Expensive Drugs in the World

The five most expensive drugs in the world from 2013 will set you back a minimum of $205,000 per year. Find out what makes these drugs so special -- and why they carry such exorbitant price tags.

Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog

Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog

Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog

Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog

Stock Picking Grades For Health Care Sector Fund Managers

Is Johnson & Johnson's Worst Nightmare Becoming Reality?

Johnson & Johnson has become a growth story on the back of strong pharmaceutical sales over the past two quarters. This trend looks like it is about to change with the approval of a rival's game-changing drug.

Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog

Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog

See More Articles...